Form EFFECT Poseida Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 10, 2025 |
| Accession Number: | 0001193125-25-003487 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Strategic Lithium Supply Chain Initiative Supports Long-Term Growth Vision
- HD Hyundai Samho Secures Order for Four Port Cranes at Port of Tacoma, Advancing MASGA Project
- LINK FOREX Deepens Its Strategic Expansion in Latin America With Major Initiatives to Build a More Professional and Resilient Investment Ecosystem
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
